4.3 Review

Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment

Related references

Note: Only part of the references are listed.
Article Neurosciences

Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo-Controlled Clinical Trial

Arianna Di Stadio et al.

Summary: This study found that combining PEA-LUT oral supplements with olfactory training resulted in better recovery of smell among patients with olfactory dysfunction post-COVID-19 compared to olfactory training alone.

CURRENT NEUROPHARMACOLOGY (2022)

Article Virology

SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway

Huanzhou Xu et al.

Summary: The study reveals that the ORF3a viroporin of SARS-CoV-2 activates the NLRP3 inflammasome, leading to heightened inflammatory response in severe COVID-19 cases. The activation of the inflammasome involves multiple molecular and cellular pathways, providing potential targets for intervention.

VIROLOGY (2022)

Review Medicine, General & Internal

Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis

Rubina Mulchandani et al.

Summary: Studies have shown significantly elevated levels of pro-inflammatory cytokines and reduced T lymphocytes in severe COVID-19 cases. However, there is heterogeneity across studies due to small sample sizes, nonuniform outcome assessment, and varied definitions of disease severity, indicating a need for well-designed and adequately powered prospective studies for more definitive answers.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Review Pharmacology & Pharmacy

Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator

Jingwei Bian et al.

Summary: This article summarizes the complex relationship between the coronavirus, ACE2, and RAS, proposing novel infection modes and pathways for virus entry mediated by ACE2, while also discussing the controversy surrounding the use of anti-RAS drugs.

ACTA PHARMACEUTICA SINICA B (2021)

Article Biochemistry & Molecular Biology

Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes

Rajendra Karki et al.

Summary: The combination of TNF-alpha and IFN-gamma induces inflammatory cell death characterized by PANoptosis, which can be inhibited to protect mice from the pathological effects and death caused by COVID-19. Blocking the cytokine-mediated inflammatory cell death signaling pathway may benefit patients with COVID-19 or other infectious and autoinflammatory diseases by limiting tissue damage/inflammation.
Article Immunology

Neuroinvasion of SARS-CoV-2 in human and mouse brain

Eric Song et al.

Summary: The study showed through three approaches that SARS-CoV-2 is capable of infecting brain neurons, leading to metabolic changes and pathological features without triggering type I interferon responses. These results provide evidence for the neuroinvasive capacity of SARS-CoV-2 and the unexpected consequence of direct infection of neurons by the virus.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Letter Neurosciences

SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation

Jessica. L. Reynolds et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology

Deidiane Elisa Ribeiro et al.

Summary: Complications of COVID-19 may cause neuroinflammatory responses, triggering and exacerbating neurological disorders. Diseases associated with neuroimmune activation may increase susceptibility to SARS-CoV-2 infection and lead to severe conditions.

MOLECULAR PSYCHIATRY (2021)

Article Neurosciences

Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

Jenny Meinhardt et al.

Summary: The study demonstrates the presence of SARS-CoV-2 in the nasopharynx and brain, suggesting the virus may enter the CNS through the olfactory mucosa. The virus utilizes the neural-mucosal interface in the olfactory mucosa to penetrate the nervous system, affecting various neuroanatomical areas, including the primary respiratory and cardiovascular control center.

NATURE NEUROSCIENCE (2021)

Article Neurosciences

The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice

Elizabeth M. Rhea et al.

Summary: The study demonstrates that the SARS-CoV-2 spike 1 protein can cross the mouse blood-brain barrier and be taken up by both the brain and peripheral tissues. Intravenous injection results in higher levels of protein uptake in the brain compared to intranasal administration. Genetic factors and sex have varying effects on the uptake of the spike protein in different tissues.

NATURE NEUROSCIENCE (2021)

Article Virology

Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice

Pratima Kumari et al.

Summary: The study demonstrated that SARS-CoV-2 infection can lead to neuroinvasion and encephalitis in K18-hACE2 mice, resulting in mortality. While the highest virus titers were observed in the lungs, high levels of infectious virus were also found in the brains of the infected mice. The severity of the disease in infected mice correlated with peak viral levels in the brain.

VIRUSES-BASEL (2021)

Review Biochemistry & Molecular Biology

COVID-19 and the human innate immune system

Joachim L. Schultze et al.

Summary: The introduction of SARS-CoV-2 into the human population has led to a significant medical and economic crisis. Innate immunity plays a central role in combating the novel virus, with variability in its components contributing to the diverse disease courses observed for COVID-19. Further research into the pathophysiological mechanisms of innate immunity is crucial for the development of diagnostic markers and therapeutic strategies targeting COVID-19.
Article Neurosciences

The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells

Jan Wenzel et al.

Summary: COVID-19 can cause damage to cerebral small vessels and neurological symptoms by infecting brain endothelial cells and cleaving NEMO through the viral protease M-pro. In animal models, the loss of NEMO leads to the generation of string vessels. Blocking RIPK3, a mediator of regulated cell death, can prevent vessel disruption caused by NEMO ablation, suggesting it as a potential therapeutic target.

NATURE NEUROSCIENCE (2021)

Review Biochemistry & Molecular Biology

Interactions of SARS-CoV-2 with the Blood-Brain Barrier

Michelle A. Erickson et al.

Summary: This review discusses the mechanisms by which SARS-CoV-2 interactions with the blood-brain barrier (BBB) may lead to neurological dysfunction associated with COVID-19. It considers peripheral diseases such as hypoxia and systemic inflammatory response syndrome, as well as CNS infection and viral entry into the brain. Additionally, it explores the contribution of risk factors for severe COVID-19 to BBB dysfunction.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Environmental Sciences

Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective

Francesco Fisicaro et al.

Summary: The current research on the neuropathology of COVID-19 deceased patients is still limited, focusing on vascular-related and infection-related inflammatory tissue damage. However, it is currently unclear whether these findings are the result of direct viral pathology or the non-specific impact of cardiovascular and pulmonary diseases on the brain.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Health Care Sciences & Services

Olfactory Training and Visual Stimulation Assisted by a Web Application for Patients With Persistent Olfactory Dysfunction After SARS-CoV-2 Infection: Observational Study

Fabrice Denis et al.

Summary: This study found that olfactory training and visual stimulation assisted by a dedicated web application significantly improved olfaction in patients, especially after at least 28 days of olfactory training.

JOURNAL OF MEDICAL INTERNET RESEARCH (2021)

Article Cell Biology

COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters

Guilherme Dias de Melo et al.

Summary: Recent investigations have shown that olfactory and taste dysfunction are common in mildly symptomatic COVID-19 patients. Research on the olfactory neuroepithelium revealed that SARS-CoV-2 infection can cause local inflammation and lead to acute loss of smell, which may account for prolonged symptoms of COVID-19 such as anosmia.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Editorial Material Psychiatry

How COVID-19 Affects the Brain

Maura Boldrini et al.

JAMA PSYCHIATRY (2021)

Article Medicine, General & Internal

Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium

Sherry H. -Y. Chou et al.

Summary: This study included patients with clinically diagnosed or laboratory-confirmed COVID-19 at 28 centers across 13 countries and 4 continents from March 1 to September 30, 2020. Neurological manifestations were prevalent among hospitalized patients with COVID-19 and were associated with higher in-hospital mortality. Patients with preexisting neurological disorders were at increased risk of developing neurological signs and/or syndromes in COVID-19.

JAMA NETWORK OPEN (2021)

Review Immunology

NLRP3 inflammasome activation and cell death

Yi Huang et al.

Summary: The NLRP3 inflammasome is a cytosolic multiprotein complex that responds to microbial infection, endogenous danger signals, and environmental stimuli. Its activation can induce pyroptosis and release of inflammatory cytokines, contributing to innate immune defense. However, aberrant activation of the NLRP3 inflammasome is associated with inflammatory diseases, and there is a close relationship between cell death pathways and NLRP3 inflammasome activation.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Immunology

Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions

Marius Schwabenland et al.

Summary: The study found profound neuroinflammation in COVID-19 patients, with activation of innate and adaptive immune cells. These pathological changes are associated with systemic inflammation and disturbed hemostasis, suggesting potential therapeutic strategies.

IMMUNITY (2021)

Article Biochemistry & Molecular Biology

A human three-dimensional neural-perivascular 'assembloid' promotes astrocytic development and enables modeling of SARS-CoV-2 neuropathology

Lu Wang et al.

Summary: Research findings suggest that pericytes may serve as important portals for SARS-CoV-2 infection in the nervous system. Introducing pericyte-like cells (PLCs) into cortical organoids can provide an experimental model that supports virus entry and replication.

NATURE MEDICINE (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation

Pan Pan et al.

Summary: This study reveals a unique mechanism by which SARS-CoV-2 N protein promotes NLRP3 inflammasome activation, leading to excessive inflammatory responses. The interaction between N protein and NLRP3 enhances the assembly of the NLRP3 inflammasome by facilitating binding with ASC.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration

Ling Zhang et al.

Summary: The study found evidence supporting that SARS-CoV-2 can cross the blood-brain barrier in transcellular pathways based on experiments in mice and hamsters. The transmission pathway involves disrupted basement membrane without obvious alteration of tight junctions.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Biochemistry & Molecular Biology

Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy

Qianqian Zhang et al.

Summary: This article reviews the current knowledge and crucial information about SARS-CoV-2 infection and antiviral therapies, focusing on how the virus attaches to host cells and undergoes fusion.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Psychiatry

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records

Maxime Taquet et al.

Summary: Our study provides evidence of significant neurological and psychiatric morbidity in the 6 months following COVID-19 infection. The risks were highest in patients with severe COVID-19. This information could assist in service planning and research priority identification.

LANCET PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys

Li Jiao et al.

Summary: This study investigated the neurotropism of SARS-CoV-2 in a non-human primate model and found that the virus primarily invades the central nervous system via the olfactory bulb, then quickly spreads to different functional regions, possibly inducing inflammation. This experimental evidence provides important insights into the CNS-related pathogenesis of SARS-CoV-2.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Review Pharmacology & Pharmacy

Inhibitors Targeting RIPK1/RIPK3: Old and New Drugs

Sofie Martens et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2020)

Article Biochemistry & Molecular Biology

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Daniel Blanco-Melo et al.

Article Immunology

Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China

Zhongliang Wang et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Critical Care Medicine

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Zhe Xu et al.

LANCET RESPIRATORY MEDICINE (2020)

Editorial Material Oncology

TMPRSS2 and COVID-19: serendipity or Opportunity for Intervention?

Konrad H. Stopsack et al.

CANCER DISCOVERY (2020)

Article Multidisciplinary Sciences

Structural basis of receptor recognition by SARS-CoV-2

Jian Shang et al.

NATURE (2020)

Letter Medicine, General & Internal

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

Thomas J. Oxley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Hematology

Platelet gene expression and function in patients with COVID-19

Bhanu Kanth Manne et al.

BLOOD (2020)

Editorial Material Immunology

The ORF3a protein of SARS-CoV-2 induces apoptosis in cells

Yujie Ren et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Review Cell Biology

Metabolome Changes in Cerebral Ischemia

Tae Hwan Shin et al.

CELLS (2020)

Review Biochemistry & Molecular Biology

Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences

Christopher S. von Bartheld et al.

ACS CHEMICAL NEUROSCIENCE (2020)

Article Multidisciplinary Sciences

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Jerome Hadjadj et al.

SCIENCE (2020)

Review Microbiology

Interplay between SARS-CoV-2 and the type I interferon response

Margarida Sa Ribero et al.

PLOS PATHOGENS (2020)

Review Neurosciences

P2X7 Interactions and Signaling - Making Head or Tail of It

Robin Kopp et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)

Review Microbiology

Origin and evolution of pathogenic coronaviruses

Jie Cui et al.

NATURE REVIEWS MICROBIOLOGY (2019)

Review Immunology

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

Karen V. Swanson et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Article Immunology

NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain

Andrea Stutz et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Article Multidisciplinary Sciences

Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion

Alexandra C. Walls et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Multidisciplinary Sciences

Pore-forming activity and structural autoinhibition of the gasdermin family

Jingjin Ding et al.

NATURE (2016)

Review Immunology

Immune Signaling by RIG-I-like Receptors

Yueh-Ming Loo et al.

IMMUNITY (2011)

Review Neurosciences

Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons

CM Anderson et al.

TRENDS IN NEUROSCIENCES (2006)

Review Pharmacology & Pharmacy

Blood-brain barrier transport of cytokines: A mechanism for neuropathology

WA Banks

CURRENT PHARMACEUTICAL DESIGN (2005)

Article Virology

Neuroinvasion by human respiratory coronaviruses

N Arbour et al.

JOURNAL OF VIROLOGY (2000)